JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Philip J. Hashkes et al.|Journal of Clinical Investigation|2018Cited by 519
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesAdriana A. de Jesus, Vibke Lilleby, Yangfeng Hou et al.|Journal of Clinical Investigation|2019Cited by 238